STAT - Reporting from the frontiers of health and medicine

STAT - Reporting from the frontiers of health and medicine

I am pleased to see Sharon’s article has generated so much attention. Thank you Sharon for exposing what is happening. Amyloid is only a symptom of Alzheimer’s it is not the cause. If you would like to learn more about what causes the amyloid in Alzheimer’s read this chapter from an evidenced based book. Here is an excerpt and I will post a link to the Chapter. Is Alzheimer’s caused by high levels of Aβ plaque? The author has Sherlock Holmes investigating the cause of a death due to Alzheimer’s. “Watson noted: “Aβ plaque is a hallmark of AD and it is found in higher than normal levels in the brain of the case of strange death. This puts Aβ plaque on the list of suspects. But is there any evidence that Aβ plaque is harmful to the brain?” Holmes replied: “No, AD-related neuron loss and dementia are mediated by Aβ oligomers, not Aβ plaque536. This is because Aβ oligomers inhibit neuronal viability ten times more that Aβ plaque and forty times more than Aβ peptides15. Soluble Aβ oligomers (e.g. clusters of soluble Aβ peptides) are converted in the brain to insoluble Aβ plaque16. Metals, such as aluminum, facilitate the conversion of Aβ peptides to Aβ oligomers and then to Aβ plaque16,17. Aβ oligomers have been isolated from the cerebral cortex and cerebrospinal fluid in concentrations six times higher than normal in the brains of AD patients18”. Watson then suggested: “Since these findings suggest that Aβ oligomers rather than Aβ plaque might be a cause of AD, we should add Aβ oligomers to our list of suspects. After all it would appear that Aβ oligomers had to be present in order to make Aβ plaque observed in the brain of the case of strange death.” Holmes replied: “Excellent deduction Watson, our new list of suspects now includes: NFTs Aβ oligomers Aluminum” http://prevent-alzheimers-autism-stroke.com/index.php/chapter-1/



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More